Dr. Sarah Young-Mi Song, MD

Dr. Song practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Song's NPI, 1760633606, was assigned on October 9, 2008. Dr. Song graduated from University of Illinois College of Medicine - Chicago in 2005. Dr. Song holds California license A108618.

Dr. Song's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Song's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. The medical group on file is Rush University Internists.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Song practices. Vendor and product names are available with a free account.

Neurology is Dr. Song's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Song is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Song's licenses on file in 4 states: California, Illinois, Indiana and District of Columbia.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, cerebrovascular disease, migraine and chronic headache, stroke and traumatic coma among the conditions Dr. Song treats.

CMS data shows 195 Medicare services from Dr. Song across 4 procedure codes in 2024, for 133 Medicare patients. Medicare paid $20,985 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 133 Medicare patients who saw Dr. Song in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Song's median patient age at 71, with 51% women.

In 2024, Dr. Song wrote 17 Medicare Part D claims. 100% of them were for generic drugs.

Dr. Song accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Song as offering telehealth.

Dmand AI links 25 papers to Dr. Song, published from 2012 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Stroke, Fibrinolytic Agents and Tissue Plasminogen Activator. Dr. Song has published most often in J Stroke Cerebrovasc Dis. Dr. Song's most frequent co-authors are James Joseph Conners, MD, Laurel Jean Cherian, MD and Amrou Sarraj, MD.

CMS Open Payments shows 9 general payments to Dr. Song from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 82% of the total. Biogen, Inc. paid the most, $1,000.

Dmand AI lists 1 award for Dr. Song, most recently CMS Stage 1 EHR in 2013.

Dr. Song graduated from University of Illinois College of Medicine - Chicago in 2005.

Dr. Song is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.